Ascension Ventures
4600 Edmundson RoadSaint Louis, MO 63134
Firm Size
- Assets Under Management (AUM):$545 Million
- Number of Funds:4
- Employees:
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Services
Healthcare
Description
Ascension Ventures is a venture capital firm located in Saint Louis, Missouri. It focuses on investing in early-stage healthcare technology companies that have the potential to bring innovation and improve patient outcomes. The firm primarily invests in companies that operate in the medical device, biotechnology, healthcare services, and digital health sectors. Ascension Ventures is a subsidiary of Ascension, the largest nonprofit healthcare system in the United States, which provides it with valuable industry insights and resources. The firm typically invests in companies during their Series A and B funding rounds, offering both financial capital as well as strategic support. With deep industry knowledge and expertise, Ascension Ventures actively plays a role in company growth by providing operational guidance and access to its extensive network of healthcare providers, payers, and other strategic partners. Its team of investment professionals works closely with portfolio companies to accelerate their growth, commercialize their products, and navigate the complex healthcare landscape. Overall, Ascension Ventures aims to foster innovation and address the challenges faced by the healthcare industry by investing in promising companies that can make a positive impact.Latest News
Powered by
Oct 24, 2023: Censys Secures $75M in New Funding
Censys, the leading Internet Intelligence Platform for Threat Hunting and Exposure Management, today announced it secured $75M in new funding. The capital raise consisted of a $50M Series C led by Decibel Partners, GV, Greylock and Intel Capital - and included new investors Ascension Ventures, Four Rivers, and accounts managed by Hamilton Lane. Additionally, the $25M in debt funding was led by SVB Capital, Silicon Valley Bank, a Division of First Citizens Bank.
Aug 15, 2023: Instylla Announces Completion of $30MM EQUITY Financing
Instylla, Inc. , a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the closing of a $30 million financing round. This financing round was led by new investor, Delos Capital, with continued participation from the investor syndicate of Excelestar Ventures, Ascension Ventures, Catalyst Health Ventures, Amed Ventures, Sparta Group, and Incept, LLC. The funds from this financing are anticipated to see Instylla through the ongoing prospective clinical trials and early commercialization.
Jun 13, 2023: LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024
LSI, the company behind LSI Emerging Medtech Summits, the partnering events for global leaders building breakthrough healthcare businesses, today announced it will host its next USA Emerging Medtech Summit, LSI USA '24, on March 18 through 22 at the Monarch Beach Resort, Waldorf Astoria in Dana Point, California .